Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

LYRA

LYRA News

Newswire

09:45

Lyra Therapeutics shares surge 21.53% intraday following positive Phase 3 ENLIGHTEN 2 trial results for LYR-210 in Chronic Rhinosinusitis.

22:25

Perceptive Advisors Sells 57,854 Shares in Lyra Therapeutics.

08:19

Lyra Therapeutics shares surge 40.20% premarket after announcing confirmatory Phase 3 trial for LYR-210 following positive ENLIGHTEN 2 data.

17:54

Lyra Therapeutics' 10% Owner Sells 46,416 Shares at Various Prices.

15:48

Lyra Therapeutics stock price falls as MACD and KDJ indicators signal bearish trend.

View More

About LYRA

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More